Disaster Nursing Course Affect Nursing Students' Disaster Literacy and Preparedness

September 30, 2024 updated by: Özüm Erkin, Izmir Democracy University

How Does the Disaster Nursing Course Affect Nursing Students' Disaster Literacy and Preparedness Perceptions?

This study aimed to examine the effect of disaster nursing course on nursing students' disaster literacy and preparedness perceptions. The study, which was a one-group quasi-experimental study design in a pretest-posttest design. Pre-test was done on September 27, 2021, and the post-test was applied on January 7, 2022. The location of the study is a public university in Izmir which is located in western part of Türkiye. The population of the study consisted of nursing students (n: 66) studying in the nursing department of the university and enrolled in the elective course "Disaster Nursing". No sample selection was made, and the study was conducted with 62 volunteer students. Individual introduction form, Disaster Literacy Scale, and Perception of Disaster Preparedness in Nurses Scale were used as tools for data collection. At the beginning of the study, data collection tools were collected online form. "Disaster nursing" course was conducted for 14 weeks as an intervention. The data were stored in the SPSS 25 program.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study aimed to examine the effect of disaster nursing course on nursing students' disaster literacy and preparedness perceptions. The study was a one-group quasi-experimental study design in a pretest-posttest design. Pre-test was done on September 27, 2021, and the post-test was applied on January 7, 2022. The location of the study is a public university in Izmir which is located in the western part of Türkiye. The population of the study consisted of nursing students (n: 66) studying in the nursing department of the university and enrolled in the elective course "Disaster Nursing". No sample selection was made, and the study was conducted with 62 volunteer students. Individual introduction form (13 questions), Disaster Literacy Scale (61 items), and Perception of Disaster Preparedness in Nurses Scale (20 items) were used as tools for data collection. At the beginning of the study, data collection tools were collected online form. "Disaster nursing" course was conducted for 14 weeks as an intervention. The descriptive statistical methods (number, percentage, mean, standard deviation), paired sample t-test, and Pearson correlation was used data analysis.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
62

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Ege Bölgesi
      • İzmir, Ege Bölgesi, Turkey, 35560
        • Izmir Democracy University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • enrollment in the disaster nursing course
  • regular attendance at meetings
  • voluntary participation in the study

Exclusion Criteria:

  • participants with any form of cognitive
  • a mental, or physical disability that interfered with communication,
  • as well as individuals with an employment history, a diploma, or a certificate in the subject of disaster

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: intervention
In this study, the "Disaster Nursing" course, which was integrated into the nursing curriculum, was an elective course, and it was carried out as a theoretical course for two hours a week. The purpose of its development was to educate students on disaster management and disaster nursing [54]. The course content included identification of risks and resources for disasters at the primary protection level, nurse's caregiver (triage and holistic care) and case manager role at the secondary protection level, reassessment of individuals' care needs at the tertiary level, and review of education and the current disaster plan at the protection level. The disaster nursing course was intended to develop students' perception of disaster awareness, preparedness, and response self-efficacy by providing them with primary, secondary, and tertiary level protection roles
Other: "Disaster Nursing" course/education
In this study, the "Disaster Nursing" course, which was integrated into the nursing curriculum, was an elective course, and it was carried out as a theoretical course for two hours a week. The topics in the content of this course regarding prevention, preparedness, response and recovery stages were designed in line with Jennings Disaster Nursing Management Model. The purpose of its development was to educate students on disaster management and disaster nursing. The course content included identification of risks and resources for disasters at the primary protection level, nurse's caregiver (triage and holistic care) and case manager role at the secondary protection level, reassessment of individuals' care needs at the tertiary level, and review of education and the current disaster plan at the protection level.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Disaster Literacy Scale (DLS)
Time Frame: 14 weeks
The conceptual framework of the 61-item scale consists of 16 domains.There are no reverse coded items in the scale. For ease of score calculation, the total score was standardized in the range of 0-50: Formula = Index = (arithmetic mean - 1) x [50/4]. With the calculated formula, cut-off points for harm reduction, preparedness, response and recovery dimensions were determined by SS values based on z-score. On the scale, 0 represents the lowest DLS and 50 represents the highest DLS. "The scale is categorized as inadequate DLS between 0-<30 points, limited DLS between 30-<36 points, adequate DLS between 36-<42 points, and excellent DLS between 42-50 points. As the scores increase in the scale, the disaster literacy level of the participant increases.
14 weeks
Nurses' Perception of Disaster Preparedness Scale
Time Frame: 14 weeks
This scale, which contains 20 items in total, consists of three sub-dimensions.The five-point Likert type scale includes the options "1-Strongly disagree, 2-Disagree, 3-Somewhat agree, 4-Agree, 5-Strongly agree" for rating. The higher the score obtained from the scale, the higher the perception of disaster preparedness.
14 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Izmir Democracy University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: özüm erkin, Ph.D, Izmir Democracy University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 27, 2021

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
January 1, 2022

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
January 7, 2022

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
May 6, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 6, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 9, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
October 2, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 30, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
September 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • IDU-SBF-ÖE-02

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings